Waking
TYVASO DPI fits into your daily routine
It is important that you take TYVASO DPI 4x daily to get the full benefit of the medicine.
TYVASO DPI
Fits in the palm of your hand
This small, portable inhaler uses cartridges and features a simple-to-use design.
- Conveniently portable
- Single-dose cartridges prefilled with medicine
- Just 1 breath per cartridge, 4x daily
Taking a dose is as simple as:
JUST ONE BREATH—OPEN, LOAD, INHALE
98% patient satisfaction rate with TYVASO DPI
TYVASO DPI received high satisfaction marks from 45 of 46 people in a clinical study who switched from the TYVASO nebulizer.*
*In the clinical study, 51 people with PAH who had been using the TYVASO nebulizer for at least 3 months switched to TYVASO DPI. Researchers recorded side effects, and after 3 weeks, 46 patients rated their satisfaction with TYVASO DPI in a questionnaire.
Lunch
Dinner
Bedtime
Reaching your target maintenance dose
Your doctor will work with you to increase your dose until you reach your target maintenance dose. This process is called “titration.”
Most people start with the 16 mcg cartridge, 4x daily, and increase their dose every 1-2 weeks until they reach their target maintenance dose.
If the prescribed dose is higher than 64 mcg per treatment session, more than 1 cartridge will be needed per session.
See the patient brochure for more information.
Watch How Simple It Is to Use TYVASO DPI
Download the full TYVASO DPI Instructions for Use manual for additional information.
Download the TYVASO DPI Titration Guide for more information on how to reach your target dose.
Get useful downloads and videos.
DPI=dry powder inhaler; PAH=pulmonary arterial hypertension.
IMPORTANT SAFETY INFORMATION
Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:
- Have low blood pressure
- Have or have had bleeding problems
IMPORTANT SAFETY INFORMATION
Before you take TYVASO or TYVASO DPI, tell your healthcare provider about all of your medical conditions, including if you:
- Have low blood pressure
- Have or have had bleeding problems
- Have asthma or chronic obstructive pulmonary disease (COPD)
- Are pregnant or plan to become pregnant. It is not known if either product will harm your unborn baby.
- Are breastfeeding or plan to breastfeed. It is not known if either product passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Either product and other medicines may affect each other.
Especially tell your healthcare provider if you take:
- Medicines used to treat high blood pressure or heart disease
- Medicines that decrease blood clotting (anticoagulants)
- Water pills (diuretics)
- Gemfibrozil (Lopid®) or rifampin (Rimactane®, Rifadin®, Rifamate®, Rifater®)
What are the possible side effects of TYVASO or TYVASO DPI?
Both products can cause serious side effects, including:
- Low blood pressure (symptomatic hypotension). If you have low blood pressure, either product may lower your blood pressure more.
- Bleeding problems. Either product may increase the risk of bleeding, especially in people who take blood thinners (anticoagulants).
The most common side effects of both products are cough, headache, throat irritation and pain, nausea, reddening of the face and neck (flushing), fainting or loss of consciousness, dizziness, diarrhea, and shortness of breath. Like other inhaled prostaglandins, you may have trouble breathing after taking TYVASO or TYVASO DPI because it may cause the muscles around your airway to tighten (bronchospasm). These are not all the possible side effects. Call your doctor for medical advice about side effects or if you have trouble breathing.
You may report side effects to the FDA at
You are now leaving the Tyvaso.com website
This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASO.com.
or call 1-800-FDA-1088.
What are TYVASO and TYVASO DPI?
TYVASO (treprostinil) Inhalation Solution and TYVASO DPI (treprostinil) Inhalation Powder are prescription medicines used in adults to treat:
- Pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO or TYVASO DPI can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO or TYVASO DPI. It is not known if TYVASO or TYVASO DPI is safe and effective in children under 18 years of age.
- Pulmonary hypertension associated with interstitial lung disease (PH-ILD; WHO Group 3), which is high blood pressure in the lungs due to inflammation and sometimes scarring in the lungs. TYVASO or TYVASO DPI can improve the ability to exercise.
The risk information provided here is not comprehensive. To learn more about TYVASO or TYVASO DPI, talk with your healthcare provider. Please see Full Prescribing Information for TYVASO or TYVASO DPI, Instructions for Use manuals for TD-100 and TD-300 TYVASO® Inhalation System and TYVASO DPI® Inhalation Powder, and additional information at www.TYVASO.com or call 1-844-UNITHER (1-844-864-8437).
TYVISIconSEP2024
